BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11133819)

  • 21. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
    Colussi C; Fiumicino S; Giuliani A; Rosini S; Musiani P; Macrí C; Potten CS; Crescenzi M; Bignami M
    J Natl Cancer Inst; 2001 Oct; 93(20):1534-40. PubMed ID: 11604476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene.
    Drotschmann K; Clark AB; Tran HT; Resnick MA; Gordenin DA; Kunkel TA
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2970-5. PubMed ID: 10077621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MSH2-deficient human cells exhibit a defect in the accurate termination of homology-directed repair of DNA double-strand breaks.
    Villemure JF; Abaji C; Cousineau I; Belmaaza A
    Cancer Res; 2003 Jun; 63(12):3334-9. PubMed ID: 12810667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defects of DNA mismatch repair in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
    Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
    Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
    Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
    Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
    Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer.
    Meira LB; Cheo DL; Reis AM; Claij N; Burns DK; te Riele H; Friedberg EC
    DNA Repair (Amst); 2002 Nov; 1(11):929-34. PubMed ID: 12531020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceleration of lymphomagenesis in mismatch-repair deficient mice by exposure to genotoxic agents.
    Jansen L; Claij N; Dekker M; van Klink Y; van der Valk M; van 't Wout K; te Riele H
    Toxicol Lett; 2000 Mar; 112-113():245-50. PubMed ID: 10720738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the lack of mismatch-repair directed antirecombination during mouse meiosis.
    Qin J; Baker S; Te Riele H; Liskay RM; Arnheim N
    J Hered; 2002; 93(3):201-5. PubMed ID: 12195036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the human APC mutation spectrum in a saccharomyces cerevisiae strain with a mismatch repair defect.
    Otsuka K; Suzuki T; Shibata H; Kato S; Sakayori M; Shimodaira H; Kanamaru R; Ishioka C
    Int J Cancer; 2003 Feb; 103(5):624-30. PubMed ID: 12494469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mismatch repair deficiency leads to a unique mode of colorectal tumorigenesis characterized by intratumoral heterogeneity.
    Habano W; Sugai T; Nakamura S
    Oncogene; 1998 Mar; 16(10):1259-65. PubMed ID: 9546427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair.
    Pichierri P; Franchitto A; Piergentili R; Colussi C; Palitti F
    Carcinogenesis; 2001 Nov; 22(11):1781-7. PubMed ID: 11698339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
    Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
    Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.
    Russo MT; De Luca G; Casorelli I; Degan P; Molatore S; Barone F; Mazzei F; Pannellini T; Musiani P; Bignami M
    Cancer Res; 2009 May; 69(10):4372-9. PubMed ID: 19435918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.
    de Wind N; Dekker M; Claij N; Jansen L; van Klink Y; Radman M; Riggins G; van der Valk M; van't Wout K; te Riele H
    Nat Genet; 1999 Nov; 23(3):359-62. PubMed ID: 10545954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.